Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bausch & Lomb U.K Limited
Bausch & Lomb House, 106 London Road, Kingston-upon-Thames, Surrey, KT2 6TN, UK
Telephone: +44 (0)208 781 2900
Fax: +44 (0)208 781 2901
Medical Information Direct Line: +44(0)1748 828849 or 08 1871 9318
Medical Information e-mail: medicalinformationuk@bausch.com
Customer Care direct line: +44 (0)208781 2991

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 15/09/2003
SPC SNO Tears


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Sno* tears


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Polyvinyl Alcohol 1.4% w/v.


Go to top of the page
3. PHARMACEUTICAL FORM

Multidose eye drops.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Sno tears is used topically to provide tear-like lubrication for the symptomatic relief of dry eyes and eye irritation associated with deficient tear production (usually in cases of keratoconjunctivitis sicca and xerophthalmia).

Sno tears is also used as an ocular lubricant for artificial eyes.


Go to top of the page
4.2 Posology and method of administration

Adults (including the elderly) and children:

The dose depends on the need for lubrication. Usually one or more drops should be used as required, or as prescribed.


Go to top of the page
4.3 Contraindications

Hypersensitivity to any component of the preparation.

This product contains benzalkonium chloride, therefore, soft contact lenses should be removed during treatment with Sno tears.


Go to top of the page
4.4 Special warnings and precautions for use

If irritation persists or worsens or headache, eye pain, vision changes or continued redness occurs, discontinue use and consult a physician.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

There is no evidence of safety of the drug in human pregnancy, but it has been in widespread use for many years without apparent ill consequence. If any therapy is needed in pregnancy, this preparation can be used if recommended by a physician.


Go to top of the page
4.7 Effects on ability to drive and use machines

May cause transient blurring of vision on instillation. Do not drive or operate hazardous machinery until vision is clear.


Go to top of the page
4.8 Undesirable effects

May cause transient, mild stinging or temporarily blurred vision.


Go to top of the page
4.9 Overdose

Not applicable.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Polyvinyl alcohol is a wetting agent and as such enables the formation of a tear film to relieve the symptoms of dry eye.


Go to top of the page
5.2 Pharmacokinetic properties

There are not expected to be any systemic reactions occurring following the use of Sno tears.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Benzalkonium Chloride

Disodium Edetate

Hydroxyethylcellulose

Sodium Chloride

Sodium Hydroxide

Purified Water


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

Unopened: 36 months

Opened: 1 month


Go to top of the page
6.4 Special precautions for storage

Store below 25°C.


Go to top of the page
6.5 Nature and contents of container

A 10ml polyethylene bottle fitted with a polyethylene plug and a tamper evident polystyrene or polyethylene pilfer proof cap.


Go to top of the page
6.6 Special precautions for disposal and other handling

Discard any remaining solution 1 month after first opening the container.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Chauvin Pharmaceuticals Ltd

106 London Road

Kingston-upon-Thames

Surrey

KT2 6TN

England


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 0033/0097


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

15.2.83 \ 14.02.98

15.2.84


Go to top of the page
10. DATE OF REVISION OF THE TEXT

October 1997

November 2002



More information about this product

  • Patient Information Leaflets (PILs):

    SNO Tears

  • Alternative format Patient Information Leaflets (X-PILs):

    SNO Tears

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/438/SPC/


Active Ingredients/Generics

 
  polyvinyl alcohol